Agony of choice-selecting chronic lymphocytic leukemia treatment in 2022 [0.03%]
慢性淋巴细胞白血病的治疗选择困境——2022年版
Jan-Paul Bohn
Jan-Paul Bohn
The treatment landscape of chronic lymphocytic leukemia (CLL) has undergone profound change in recent years. Targeted therapies have outnumbered chemotherapy-based treatment approaches demonstrating superior efficacy and tolerability profil...
Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report [0.03%]
一例接受粒细胞集落刺激因子治疗后发生系统性毛细血管漏综合征的T淋巴母细胞白血病/淋巴瘤患者的病例报告
Ahmed H Al Sharie,Yazan O Al Zubi,Sarah Al Sharie et al.
Ahmed H Al Sharie et al.
Introduction: Systemic capillary leak syndrome (SCLS) is a rare and often fatal clinical entity used to describe a generalized increase in vascular permeability leading to fluid extravasation toward the interstitial compa...
Pınar Tığlıoğlu,Murat Albayrak,Mesut Tığlıoğlu et al.
Pınar Tığlıoğlu et al.
Objective: The aim of this study was to examine the effect of coronavirus disease 2019 (COVID-19) on the malignancy-related clinical course and overall survival, and to determine the factors affecting mortality. ...
Öykü Umut,Adrian Gottschlich,Stefan Endres et al.
Öykü Umut et al.
Chimeric antigen receptor (CAR) T cell therapy has been established in the treatment of hematological malignancies. However, in solid tumors its efficacy remains limited. The aim of this article is to give an overview of the field of cell t...
Practical considerations for the management of immune thrombocytopenic purpura [0.03%]
免疫性血小板减少性紫癜治疗的实际情况考虑
Michael Fillitz,Barbara Dixer,Felix Keil
Michael Fillitz
Immune thrombocytopenic purpura (ITP) is a rare hematological disorder with an autoimmune-mediated, often dramatic reduction of platelets in peripheral blood. Thrombocytopenia results from a reduced life span of thrombocytes and an addition...
Interesting news from the annual meeting of the American Society of Hematology 2020 [0.03%]
2020年美国血液学年度会议上的有趣新闻
Eberhard Gunsilius
Eberhard Gunsilius
Editorial
Memo. 2021;14(3):215. DOI:10.1007/s12254-021-00733-1 2021
Lethal human metavirus pneumonia in a patient with chronic lymphocytic leukemia [0.03%]
一例慢性淋巴细胞性白血病患者合并致命性人类副黏病毒肺炎病例报告
Holger Rumpold
Holger Rumpold
Human metapneumovirus (HMPV) causes a flu-like disease in humans. Most infections occur in early childhood, but reinfections during life are common. The clinical course of these infections are usually mild and do not require hospitalization...
Chronic lymphocytic leukaemia-what is new and notable in 2021, with a special focus on COVID-19 [0.03%]
慢性淋巴细胞白血病——2021年值得关注的新进展(特别关注COVID-19)
Katharina T Prochazka,Peter Neumeister
Katharina T Prochazka
In the last few years, treatment of patients exhibiting chronic lymphocytic leukaemia has changed extensively due to advances in the development of targeted therapies. The role of immunochemotherapy has been for the most part replace and th...